EA201690229A1 - Способ получения дронедарона и его солей - Google Patents

Способ получения дронедарона и его солей

Info

Publication number
EA201690229A1
EA201690229A1 EA201690229A EA201690229A EA201690229A1 EA 201690229 A1 EA201690229 A1 EA 201690229A1 EA 201690229 A EA201690229 A EA 201690229A EA 201690229 A EA201690229 A EA 201690229A EA 201690229 A1 EA201690229 A1 EA 201690229A1
Authority
EA
Eurasian Patent Office
Prior art keywords
salts
dronedarona
obtaining
methods
pharmaceutically acceptable
Prior art date
Application number
EA201690229A
Other languages
English (en)
Inventor
Йоханн Чан
Джастин Витэйл
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Publication of EA201690229A1 publication Critical patent/EA201690229A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials Engineering (AREA)
  • Furan Compounds (AREA)
  • Epidemiology (AREA)

Abstract

Настоящее изобретение относится к способам получения дронедарона или его фармацевтически приемлемых солей.
EA201690229A 2013-08-27 2014-08-26 Способ получения дронедарона и его солей EA201690229A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361870632P 2013-08-27 2013-08-27
US201361903285P 2013-11-12 2013-11-12
PCT/US2014/052692 WO2015031352A1 (en) 2013-08-27 2014-08-26 Process for preparing dronedarone and salts thereof

Publications (1)

Publication Number Publication Date
EA201690229A1 true EA201690229A1 (ru) 2016-07-29

Family

ID=51492497

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690229A EA201690229A1 (ru) 2013-08-27 2014-08-26 Способ получения дронедарона и его солей

Country Status (15)

Country Link
US (1) US9242953B2 (ru)
EP (1) EP3039016B1 (ru)
JP (1) JP2016534120A (ru)
KR (1) KR20160045880A (ru)
CN (1) CN105452232A (ru)
AU (1) AU2014311399B2 (ru)
CA (1) CA2921201A1 (ru)
EA (1) EA201690229A1 (ru)
HK (2) HK1217194A1 (ru)
IL (1) IL243886A0 (ru)
MX (1) MX2016002186A (ru)
SG (1) SG11201600763TA (ru)
TW (1) TW201536763A (ru)
UY (1) UY35715A (ru)
WO (1) WO2015031352A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114456135A (zh) * 2022-03-18 2022-05-10 江苏慧聚药业股份有限公司 决奈达隆的制备

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
FR2817864B1 (fr) * 2000-12-11 2003-02-21 Sanofi Synthelabo Derive de methanesulfonamido-benzofurane, son procede de preparation et son utilisation comme intermediaire de synthese
US8108698B2 (en) * 2008-06-04 2012-01-31 Broadcom Corporation Computer storage components that provide external and internal access
AU2011213921A1 (en) * 2010-02-10 2012-08-09 Mapi Pharma Limited Preparation of benzofurans and use thereof as synthetic intermediates
FR2957079B1 (fr) * 2010-03-02 2012-07-27 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
FR2958289B1 (fr) * 2010-03-30 2012-06-15 Sanofi Aventis Procede de preparation de derives de 3-ceto-benzofurane
HUP1000330A2 (en) * 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
HUP1000386A2 (en) * 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
FR2973027A1 (fr) 2011-03-24 2012-09-28 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
WO2013014480A1 (en) 2011-07-26 2013-01-31 Sanofi Process for preparation of dronedarone using amide intermediary compound
EP2617718A1 (en) * 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent

Also Published As

Publication number Publication date
US20150065734A1 (en) 2015-03-05
UY35715A (es) 2015-02-27
TW201536763A (zh) 2015-10-01
EP3039016B1 (en) 2017-08-02
HK1219949A1 (zh) 2017-04-21
HK1217194A1 (zh) 2016-12-30
US9242953B2 (en) 2016-01-26
JP2016534120A (ja) 2016-11-04
CA2921201A1 (en) 2015-03-05
SG11201600763TA (en) 2016-02-26
EP3039016A1 (en) 2016-07-06
AU2014311399B2 (en) 2017-06-15
CN105452232A (zh) 2016-03-30
KR20160045880A (ko) 2016-04-27
AU2014311399A1 (en) 2016-02-25
MX2016002186A (es) 2016-06-06
WO2015031352A1 (en) 2015-03-05
IL243886A0 (en) 2016-04-21

Similar Documents

Publication Publication Date Title
EA202092987A3 (ru) Липид, содержащий докозапентаеновую кислоту
EA201691214A1 (ru) Антитела к cd33 и иммуноконъюгаты
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201691648A1 (ru) Способ получения противогрибковых соединений
EA201691649A1 (ru) Способ получения противогрибковых соединений
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
EA201690844A1 (ru) Ингибиторы gsk-3
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
EA201591380A1 (ru) АНТАГОНИСТЫ Kv1.3 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
EA201690396A1 (ru) Производное ванкомицина, способ его получения и его применение
EA201692288A1 (ru) Способ получения фосфорсодержащих циангидринов
EA201690263A1 (ru) Улучшенные способы получения перампанеля
IN2013MU01113A (ru)
EA201500927A1 (ru) Твердые липидные наночастицы (i)
UY34277A (es) Metodo para la eliminación del naftaleno